Fig. 3From: Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in JapanAnnual change of HBOC and RRSO cases. The number of patients who were diagnosed with HBOC were 24 (4/year) and 18 (10/year) and RRSO was performed for 7 (1/year) and 11 (6/year) patients in the pre- and post-coverage periods, respectively. HBOC: hereditary breast and ovarian cancer, RRSO: risk-reducing salpingo-oophorectomyBack to article page